Literature DB >> 9802632

Inflammatory mediators in Escherichia coli O157:H7 hemorrhagic colitis and hemolytic-uremic syndrome.

F Proulx1, J P Turgeon, C Litalien, M M Mariscalco, P Robitaille, E Seidman.   

Abstract

BACKGROUND: Recent experimental data suggest that the inflammatory response of the host to verotoxin and/or lipopolysaccharides of Escherichia coli is involved in the pathophysiology of verotoxin-producing E. coli (VTEC) infections.
METHODS: We measured the circulating concentrations of cytokines [TNF-alpha, interleukin (IL)-1-beta, IL-1 receptor antagonist (Ra), IL-6, IL-8, IL-10] and soluble leukocyte adhesion molecules (L-selectin, P-selectin, E-selectin, intracellular cell adhesion molecule-1, vascular cell adhesion molecule-1) by sandwich enzyme-linked immunosorbent assay among (1) normal controls (n = 12), (2) disease controls with hemorrhagic colitis (HC) not associated with VTEC infections (n = 57), (3) patients with uncomplicated HC caused by E. coli O157:H7 (n = 30), and (4) children with hemolytic-uremic syndrome (HUS) (n = 28). Patients with HUS were matched with children who presented an uncomplicated HC caused by E. coli O157:H7 for the time interval elapsed between the onset of HC and that of blood sample collection.
RESULTS: Concentrations of TNF-alpha and IL-1-beta were undetectable. Children with HUS were characterized by increased amounts of IL-6 and IL-8, lower values of soluble L-selectin as well as increased levels of IL-10 and IL-1Ra. The circulating concentrations of IL-1Ra were higher among children with O157:H7 HC who subsequently developed HUS.
CONCLUSIONS: Increased pro- and antiinflammatory cytokine responses are produced by the host during the development of HUS among children with VTEC infections. Further studies are needed to determine their relative contribution to the pathophysiology of classic HUS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9802632     DOI: 10.1097/00006454-199810000-00010

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  17 in total

1.  Increased circulating levels of lipopolysaccharide binding protein in children with Escherichia coli O157:H7 hemorrhagic colitis and hemolytic uremic syndrome.

Authors:  F Proulx; E Seidman; M M Mariscalco; K Lee; S Caroll
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

2.  Shiga Toxin-Producing Escherichia coli.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

3.  Increased levels of macrophage migration inhibitory factor in sera of patients with Escherichia coli O157:H7-induced enterocolitis.

Authors:  Tatsuya Ohkawara; Hiroshi Takeda; Masahiro Asaka; Yuka Mizue; Jun Nishihira
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

4.  Serum ferritin as an indicator of the development of encephalopathy in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome.

Authors:  Masaki Shimizu; Natsumi Inoue; Mondo Kuroda; Hitoshi Irabu; Maiko Takakura; Hisashi Kaneda; Naotoshi Sugimoto; Kazuhide Ohta; Akihiro Yachie
Journal:  Clin Exp Nephrol       Date:  2017-03-10       Impact factor: 2.801

5.  Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide.

Authors:  Deborah J Stearns-Kurosawa; Valta Collins; Scott Freeman; Diann Debord; Kiyotaka Nishikawa; Sun-Young Oh; Caitlin S Leibowitz; Shinichiro Kurosawa
Journal:  Pediatr Nephrol       Date:  2011-05-21       Impact factor: 3.714

6.  Administration of ricin induces a severe inflammatory response via nonredundant stimulation of ERK, JNK, and P38 MAPK and provides a mouse model of hemolytic uremic syndrome.

Authors:  Veselina Korcheva; John Wong; Christopher Corless; Mihail Iordanov; Bruce Magun
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

7.  Characterization of the cytokine immune response in children who have experienced an episode of typical hemolytic-uremic syndrome.

Authors:  Soeren Westerholt; Anne-Kathrin Pieper; Martin Griebel; Hans-Dieter Volk; Thomas Hartung; Renate Oberhoffer
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

8.  Angiopoietin-1 and -2 as markers for disease severity in hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.

Authors:  Masaki Shimizu; Natsumi Inoue; Mondo Kuroda; Mao Mizuta; Naotoshi Sugimoto; Hisashi Kaneda; Kazuhide Ohta; Akihiro Yachie
Journal:  Clin Exp Nephrol       Date:  2016-03-05       Impact factor: 2.801

9.  Hemolytic uremic syndrome: Events of the past decade.

Authors:  Peter N McLaine
Journal:  Paediatr Child Health       Date:  2002-10       Impact factor: 2.253

10.  Age-Related Changes of Serum Soluble Interleukin 9 Receptor (sIL-9Rα) in Healthy Subjects.

Authors:  Yoshihiro Okamoto; Mayuri Tanaka; Asami Kasahara; Takazumi Hara; Yoshimitsu Gotoh; Naoya Fujita; Takashi Fukui; Toshiyuki Masuzawa
Journal:  Indian J Clin Biochem       Date:  2012-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.